MORE than 5,000 patients have benefitted from subsidised access to plant-based treatments since Medcan's Compassionate Access Program (CAP), Cann I Help, began.
The program assists eligible patients to cover the cost of medicinal cannabis products that they otherwise may not be able to afford, the company stated.
"This amounts to $1.6 million dollars since we launched the program in 2020," said Medcan co-founder Gareth Ball.
"The CAP is our way of offering a helping hand and it makes a significant difference to so many people's lives, for example, patients with palliative care needs or those suffering from cancer are eligible for product subsidises of up to 50%."
The milestone comes soon after the Cann I Help network was awarded Best Clinic/Telehealth Service of the Year at the 2023 Aust/NZ Cannabiz Awards.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jun 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jun 23
Warning: Undefined variable $o_shortcode_atts in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1263
Warning: Undefined variable $output in /home/pharmacydaily.com.au/public_html/wp-content/themes/child-custom-theme/functions.php on line 1266
